# Vitamin B12 Deficiency in Pernicious Anemia: A Hemolytic Anemia Mimic

**Authors:** Nasim Salimiaghdam, Omar Jumaah, Talar Acob, Knkush Hakobyan, Emily Chen

PMC · DOI: 10.7759/cureus.79176 · Cureus · 2025-02-17

## TL;DR

A case study shows how vitamin B12 deficiency can mimic hemolytic anemia and highlights the importance of accurate diagnosis and treatment.

## Contribution

The paper presents a clinical case emphasizing the importance of recognizing vitamin B12 deficiency as a reversible cause of hemolysis.

## Key findings

- A 60-year-old woman with vitamin B12 deficiency showed symptoms resembling hemolytic anemia.
- Treatment with cyanocobalamin injections led to significant improvement in blood parameters.
- The case underscores the need to differentiate vitamin B12 deficiency from thrombotic microangiopathy.

## Abstract

Vitamin B12 deficiency can lead to a wide range of clinical symptoms and may resemble hemolytic anemia due to ineffective red blood cell production and hemolysis occurring within the bone marrow. Identifying this deficiency as a possible cause of hemolysis is essential to prevent misdiagnosis, especially when distinguishing it from thrombotic microangiopathy. We present a case involving a 60-year-old woman with a history of hypertension and type 2 diabetes who came in with symptoms of generalized weakness, dizziness, nausea, and abdominal pain. Laboratory tests showed pancytopenia, macrocytosis, and signs of hemolysis. Further investigation confirmed a severe vitamin B12 deficiency linked to pernicious anemia. After starting weekly intramuscular cyanocobalamin injections for the first month and then switching to monthly injections for four months post-discharge, her blood parameters showed significant improvement. This underlines the vital role of timely diagnosis and following established treatment protocols. This case emphasizes the importance of considering vitamin B12 deficiency as a reversible cause of hemolysis. It highlights the need to differentiate it from more serious hematologic disorders such as thrombotic microangiopathy to ensure proper management.

## Linked entities

- **Chemicals:** cyanocobalamin (PubChem CID 166596686)
- **Diseases:** vitamin B12 deficiency (MONDO:0020696), pernicious anemia (MONDO:0008228), hemolytic anemia (MONDO:0003664), thrombotic microangiopathy (MONDO:0019737), type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Diseases:** abdominal pain (MESH:D015746), pancytopenia (MESH:D010198), Vitamin B12 Deficiency (MESH:D014806), hypertension (MESH:D006973), Hemolytic Anemia (MESH:D000743), type 2 diabetes (MESH:D003924), macrocytosis (MESH:C564004), dizziness (MESH:D004244), nausea (MESH:D009325), Pernicious Anemia (MESH:D000752), thrombotic microangiopathy (MESH:D057049), weakness (MESH:D018908), hemolysis (MESH:D006461), hematologic disorders (MESH:D006402)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11922497/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11922497/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC11922497/full.md

---
Source: https://tomesphere.com/paper/PMC11922497